Neurelis, Inc.
Overview
Neurelis, Inc. is a neuroscience-based biotechnology company focused on developing and commercializing product candidates for the treatment of epilepsy and other central nervous system disorders. The company is renowned for its innovative therapies designed to enhance patient care.
Therapeutic areas
EpilepsyCentral Nervous System Disorders
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Neurelis, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.